PLRX - Pliant Therapeutics Inc
1.33
-0.060 -4.511%
Share volume: 289,680
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$1.39
-0.06
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-07-2024 | 11-07-2024 | 03-03-2025 | 05-08-2025 | 11-06-2025 | |
| Assets | |||||||
| Total Assets | 521.605 M | 483.730 M | 445.665 M | 396.949 M | 344.770 M | 276.600 M | |
| Current Assets | 489.898 M | 447.553 M | 410.031 M | 362.264 M | 311.191 M | 245.588 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 7.509 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 7.509 M | 356.221 M | 324.897 M | 284.536 M | 213.709 M | 148.065 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 482.389 M | 80.386 M | 79.616 M | 71.188 M | 91.936 M | 93.732 M | |
| Total Non-current Assets | 31.707 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.605 M | 5.395 M | 5.671 M | 5.525 M | 5.240 M | 4.344 M | |
| Other Assets | 24.620 M | 30.782 M | 29.963 M | 29.160 M | 28.339 M | 26.668 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 521.605 M | 483.730 M | 445.665 M | 396.949 M | 344.770 M | 276.600 M | |
| Total liabilities | 84.273 M | 91.052 M | 99.843 M | 92.868 M | 87.606 M | 76.294 M | |
| Total current liabilities | 30.391 M | 30.924 M | 39.952 M | 33.218 M | 28.203 M | 17.624 M | |
| Accounts Payable | 7.327 M | 3.247 M | 6.890 M | 5.960 M | 5.622 M | 485.000 K | |
| Other liabilities | 0.000 | 30.058 M | 29.752 M | 29.439 M | 29.119 M | 28.231 M | |
| Current long term debt | 773.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 53.882 M | 30.070 M | 30.139 M | 30.211 M | 30.284 M | 30.439 M | |
| Other liabilities | 0.000 | 30.058 M | 29.752 M | 29.439 M | 29.119 M | 28.231 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 437.332 M | 392.678 M | 345.822 M | 304.081 M | 257.164 M | 200.306 M | |
| Common stock | 60.181 M | 995.852 M | 1.005 B | 1.014 B | 1.023 B | 1.036 B | |
| Retained earnings | -546.703 M | -602.557 M | -660.320 M | -710.052 M | -766.218 M | -835.819 M |